465 related articles for article (PubMed ID: 15856526)
1. Roles for USF-2 in lung cancer proliferation and bronchial carcinogenesis.
Ocejo-Garcia M; Baokbah TA; Ashurst HL; Cowlishaw D; Soomro I; Coulson JM; Woll PJ
J Pathol; 2005 Jun; 206(2):151-9. PubMed ID: 15856526
[TBL] [Abstract][Full Text] [Related]
2. Upstream stimulatory factor activates the vasopressin promoter via multiple motifs, including a non-canonical E-box.
Coulson JM; Edgson JL; Marshall-Jones ZV; Mulgrew R; Quinn JP; Woll PJ
Biochem J; 2003 Feb; 369(Pt 3):549-61. PubMed ID: 12403649
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of the polymeric immunoglobulin receptor in non-small cell lung carcinoma: correlation with dysregulated expression of the transcription factors USF and AP2.
Khattar NH; Lele SM; Kaetzel CS
J Biomed Sci; 2005; 12(1):65-77. PubMed ID: 15864740
[TBL] [Abstract][Full Text] [Related]
4. Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers.
Woenckhaus M; Klein-Hitpass L; Grepmeier U; Merk J; Pfeifer M; Wild P; Bettstetter M; Wuensch P; Blaszyk H; Hartmann A; Hofstaedter F; Dietmaier W
J Pathol; 2006 Oct; 210(2):192-204. PubMed ID: 16915569
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
6. Loss of FHIT function in lung cancer and preinvasive bronchial lesions.
Sozzi G; Pastorino U; Moiraghi L; Tagliabue E; Pezzella F; Ghirelli C; Tornielli S; Sard L; Huebner K; Pierotti MA; Croce CM; Pilotti S
Cancer Res; 1998 Nov; 58(22):5032-7. PubMed ID: 9823304
[TBL] [Abstract][Full Text] [Related]
7. Apoptotic markers p53, Bcl-2 and Bax in primary lung cancer.
Porebska I; Wyrodek E; Kosacka M; Adamiak J; Jankowska R; Harłozińska-Szmyrka A
In Vivo; 2006; 20(5):599-604. PubMed ID: 17091766
[TBL] [Abstract][Full Text] [Related]
8. Loss of pRb2/p130 expression is associated with unfavorable clinical outcome in lung cancer.
Caputi M; Groeger AM; Esposito V; De Luca A; Masciullo V; Mancini A; Baldi F; Wolner E; Giordano A
Clin Cancer Res; 2002 Dec; 8(12):3850-6. PubMed ID: 12473599
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
[TBL] [Abstract][Full Text] [Related]
10. Differential expression and distribution of epithelial adhesion molecules in non-small cell lung cancer and normal bronchus.
Boelens MC; van den Berg A; Vogelzang I; Wesseling J; Postma DS; Timens W; Groen HJ
J Clin Pathol; 2007 Jun; 60(6):608-14. PubMed ID: 16489176
[TBL] [Abstract][Full Text] [Related]
11. Gene amplification is a relatively frequent event leading to ZBTB7A (Pokemon) overexpression in non-small cell lung cancer.
Apostolopoulou K; Pateras IS; Evangelou K; Tsantoulis PK; Liontos M; Kittas C; Tiniakos DG; Kotsinas A; Cordon-Cardo C; Gorgoulis VG
J Pathol; 2007 Nov; 213(3):294-302. PubMed ID: 17907153
[TBL] [Abstract][Full Text] [Related]
12. C-CAM1, a candidate tumor suppressor gene, is abnormally expressed in primary lung cancers.
Wang L; Lin SH; Wu WG; Kemp BL; Walsh GL; Hong WK; Mao L
Clin Cancer Res; 2000 Aug; 6(8):2988-93. PubMed ID: 10955775
[TBL] [Abstract][Full Text] [Related]
13. Loss of USF transcriptional activity in breast cancer cell lines.
Ismail PM; Lu T; Sawadogo M
Oncogene; 1999 Sep; 18(40):5582-91. PubMed ID: 10523835
[TBL] [Abstract][Full Text] [Related]
14. Does c-erbB-2 play a role in the first steps of lung carcinogenesis?
Meert AP; Martin B; Verdebout JM; Ninane V; Sculier JP
Anticancer Res; 2005; 25(3B):2005-8. PubMed ID: 16158937
[TBL] [Abstract][Full Text] [Related]
15. Frequent loss of gelsolin expression in non-small cell lung cancers of heavy smokers.
Dosaka-Akita H; Hommura F; Fujita H; Kinoshita I; Nishi M; Morikawa T; Katoh H; Kawakami Y; Kuzumaki N
Cancer Res; 1998 Jan; 58(2):322-7. PubMed ID: 9443412
[TBL] [Abstract][Full Text] [Related]
16. Nuclear factor-kappaB (NF-kappaB) is frequently expressed in lung cancer and preneoplastic lesions.
Tang X; Liu D; Shishodia S; Ozburn N; Behrens C; Lee JJ; Hong WK; Aggarwal BB; Wistuba II
Cancer; 2006 Dec; 107(11):2637-46. PubMed ID: 17078054
[TBL] [Abstract][Full Text] [Related]
17. Bcl-2 protein expression in lung cancer and close correlation with neuroendocrine differentiation.
Jiang SX; Kameya T; Sato Y; Yanase N; Yoshimura H; Kodama T
Am J Pathol; 1996 Mar; 148(3):837-46. PubMed ID: 8774138
[TBL] [Abstract][Full Text] [Related]
18. [Nuclear factor-kappaB activity and its correlation with cell proliferation in non-small cell lung cancer tissues].
Zhang J; Xu YJ; Zhang ZX; DU CL; Qiao LF; Ni W; Chen SX
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Oct; 30(10):771-5. PubMed ID: 18218209
[TBL] [Abstract][Full Text] [Related]
19. Distinct pattern of E2F1 expression in human lung tumours: E2F1 is upregulated in small cell lung carcinoma.
Eymin B; Gazzeri S; Brambilla C; Brambilla E
Oncogene; 2001 Mar; 20(14):1678-87. PubMed ID: 11313916
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of tissue localization of cytokeratin 19 in lung cancer.
Chyczewski L; Nikliński J; Chyczewska E; Laudański J; Furman M
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():162-72. PubMed ID: 9337534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
